Clinical Trials Directory

Trials / Completed

CompletedNCT01950897

Muscle Tissue Bank for Muscular Dystrophy

Establishment of Phenotypic Profiles of Muscular Dystrophies for Understanding Disease Progression, Diagnosis and Development of New Therapies

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Accepted

Summary

This protocol proposes to establish gene expression profiles of muscular dystrophies for correct diagnosis and for development of experimental therapies for these diseases.

Detailed description

Muscular dystrophies are caused by mutations in more than 30 genes, some of them remaining to be identified. Phenotypically, it is known that one specific mutation can affect the expression of several other proteins causing difficulty in diagnosis. Correct genotyping is essential for diagnosis, prognosis and treatment, and relies on a complexed analysis of muscle tissues for phenotype profiles. Our research aims to understand how different gene mutations affect expression of other genes via muscle biopsy samples and establishment of phenotypic profiles for correct diagnosis of individual patients. Establishment of such information will be critical for understanding the progression of different muscular dystrophies and to devise new experimental therapies. This research will also provide vital clues for finding new genes involved in the disease process. Muscle samples may also be used to establish cell cultures for testing drugs and new therapies relevant to the treatment of the muscular dystrophies.

Conditions

Timeline

Start date
2005-08-24
Primary completion
2015-01-30
Completion
2015-06-09
First posted
2013-09-26
Last updated
2022-04-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01950897. Inclusion in this directory is not an endorsement.